Philips (ENXTAM:PHIA) received FDA clearance for its AI-powered DeviceGuide to support mitral valve repair procedures. The company also launched IntraSight Plus, an integrated platform designed to ...
Philips has secured an FDA clearance for its artificial intelligence program that tracks and guides the placement of a ...
Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools ...
Philips (NYSE:PHG) today announced the launch of its IntraSight Plus interventional guidance platform in the U.S. and Europe.
March 26, 2026Philips DeviceGuide uses AI to track and visualize mitral valve repair devices [1] in real time during minimally invasive ...
New integration of Philips Advanced Visualization Workspace* with the Azurion image-guided therapy platform automatically synchronizes CT images with C-arm movement, supporting workflow efficiency and ...
King's Daughters Medical Center yesterday opened a new cardiac catheterization lab that is the first of its kind in the nation. The lab features equipment and software with enhanced capabilities from ...
PARIS – A meta-analysis covering 4,529 patients presented at EuroPCR closed the door on a five-year argument over what diagnostic tool will be the gold standard in the catheterization lab for helping ...
The Florida Institute for Angiography, of Sarasota, better known as fiaHeart, held a grand reopening Feb. 25 to celebrate the unveiling of its newly renovated Cath Lab. The Philips Azurion Cath Lab, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results